Patil; Ghanshyam

Patent Applications and Registrations

Patent applications and USPTO patent grants for Patil; Ghanshyam.The latest application filed is for "amelioration of the development of cataracts and other ophthalmic diseases".

Company Profile

0.8.16

Patil; Ghanshyam - Lincoln University PA
Patil; Ghanshyam - Vernon Hills IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Amelioration Of The Development Of Cataracts And Other Ophthalmic Diseases App 20130131052 - Matier; William L. ; et al.	2013-05-23
Amelioration of the development of cataracts and other ophthalmic diseases Grant 8,383,648 - Matier , et al. February 26, 2	2013-02-26
Amelioration of cataracts, macular degeneration and other ophthalmic diseases Grant 7,825,134 - Matier , et al. November 2, 2	2010-11-02
Oculoselective Drugs And Prodrugs App 20100179218 - MATIER; WILLIAM L. ; et al.	2010-07-15
Oculoselective drugs and prodrugs Grant 7,678,829 - Matier , et al. March 16, 2	2010-03-16
Amelioration of vitrectomy-induced cataracts Grant 7,589,107 - Matier , et al. September 15, 2	2009-09-15
Use of Hydroxylamine Derivates for Inhibiting Vitrectomy-Induced Cataracts App 20080312283 - Matier; William L ; et al.	2008-12-18
Hydroxylamine Compounds And Methods Of Their Use App 20080280890 - Patil; Ghanshyam	2008-11-13
Amelioration Of The Development Of Cataracts And Other Ophthalmic Diseases App 20080274983 - Matier; William L. ; et al.	2008-11-06
Amelioration of the development of cataracts and other ophthalmic diseases Grant 7,442,711 - Matier , et al. October 28, 2	2008-10-28
Drug Resistance Reversal In Neoplastic Disease App 20080200405 - Patil; Ghanshyam ; et al.	2008-08-21
Oculoselective Drugs and Prodrugs App 20070254950 - Matier; William L. ; et al.	2007-11-01
Hydroxylamines and derivatives for the inhibition of complement activation App 20070203190 - Patil; Ghanshyam ; et al.	2007-08-30
Hydroxylamines And Derivatives As Anti-angiogenic Agents App 20070197599 - Matier; William L. ; et al.	2007-08-23
Hydroxylamines And Derivatives For Treatment Of Inflammatory Conditions Of The Liver App 20070197593 - Matier; William L. ; et al.	2007-08-23
Amelioration of vitrectomy-induced cataracts App 20060292190 - Matier; William L. ; et al.	2006-12-28
Oculoselective drugs and prodrugs App 20060019955 - Matier; William L. ; et al.	2006-01-26
Amelioration of macular degeneration and other ophthalmic diseases App 20050130906 - Matier, William L. ; et al.	2005-06-16
Amelioration of cataracts, macular degeneration and other ophthalmic diseases App 20050131025 - Matier, William L. ; et al.	2005-06-16
Amelioration of the development of cataracts and other ophthalmic diseases App 20040002461 - Matier, William L. ; et al.	2004-01-01
Optically active aryloxypropanolamines and arylethanolamines Grant 4,990,668 - Mai , et al. February 5, 1	1991-02-05
Process for the preparation of 2-(1-hydroxyalkyl)-5,5-diphenylhydantoin Grant 4,709,042 - Mai , et al. November 24, 1	1987-11-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.